Concepedia
Statistics
Publications
8
Citations
544
H-Index
Active since
2010
Affiliations
Incyte (United States)(Current)
Experimental Station
Pfizer (United States)
Joseph Glenn is an author at Incyte (United States) specializing in pharmacology, drug discovery, and medicinal chemistry.
Publications per year
2010–2019
INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology
Eddy W. Yue, Richard Sparks, Padmaja Polam et al. · ACS Medicinal Chemistry Letters · 2017 · 296 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +8
INCB050465 (Parsaclisib), a Novel Next-Generation Inhibitor of Phosphoinositide 3-Kinase Delta (PI3Kδ)
Eddy W. Yue, Yunlong Li, Brent Douty et al. · ACS Medicinal Chemistry Letters · 2019 · 49 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +14
Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist
Chu‐Biao Xue, Hao Feng, Ganfeng Cao et al. · ACS Medicinal Chemistry Letters · 2011 · 48 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +17
Discovery of INCB8761/PF-4136309, a Potent, Selective, and Orally Bioavailable CCR2 Antagonist
Chu‐Biao Xue, Anlai Wang, Qi Han et al. · ACS Medicinal Chemistry Letters · 2011 · 46 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +9
Discovery of INCB3344, a potent, selective and orally bioavailable antagonist of human and murine CCR2
Chu‐Biao Xue, Anlai Wang, David Meloni et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 41 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +6
1–5 of 8